Submission Details
| 510(k) Number | K163095 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 04, 2016 |
| Decision Date | February 01, 2017 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K163095 is an FDA 510(k) clearance for the Lyme B. burgdorferi (IgG) MarStripe Test, a Reagent, Borrelia Serological Reagent (Class II — Special Controls, product code LSR), submitted by Trinity Biotech (Buffalo, US). The FDA issued a Cleared decision on February 1, 2017, 89 days after receiving the submission on November 4, 2016. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K163095 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 04, 2016 |
| Decision Date | February 01, 2017 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LSR — Reagent, Borrelia Serological Reagent |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |